InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Murdock Hunter R.. Director active across 1 company, notably Axsome Therapeutics, Inc.. In total, 2 filings have been published. Activity tracked since 16 June 2025. The latest transaction was disclosed on 20 June 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations